```html

Fungal Conjunctivitis – Comprehensive Medical Guide

Overview

Fungal conjunctivitis (also called mycotic conjunctivitis) is an inflammation of the conjunctiva—the thin, transparent membrane that lines the inside of the eyelids and covers the white part of the eye—caused by fungal organisms. While bacterial and viral conjunctivitis are far more common, fungi can invade the ocular surface, especially in certain environments or among people with compromised immune systems.

Who it affects: The condition can occur at any age, but it is most frequently reported in:

• Adults living in tropical or subtropical climates where fungi thrive.
• Individuals with chronic ocular surface disease (dry eye, blepharitis).
• People using prolonged topical steroids or immunosuppressive eye drops.
• Patients with systemic immunosuppression (e.g., HIV/AIDS, chemotherapy, organ transplant recipients).

Prevalence: Fungal conjunctivitis accounts for less than 1 % of all conjunctivitis cases worldwide, according to the World Health Organization (WHO). In regions with high humidity and agricultural activity (e.g., parts of Southeast Asia, Central America), isolated outbreaks have been documented, with incidences ranging from 0.3 to 2 cases per 10,000 population per year (CDC, 2022).

Symptoms

Symptoms can be subtle early on and may overlap with bacterial or viral conjunctivitis. A thorough history helps differentiate them.

Typical clinical manifestations

• Redness (hyperemia): Diffuse or localized pinkness of the sclera.
• Discharge: Thick, often creamy or “pus‑like” material. Unlike viral discharge (watery), fungal discharge may have a pasty consistency and occasional yellow‑brown specks.
• Itching and burning: Persistent irritation that may worsen in warm, humid environments.
• Foreign‑body sensation: The eye feels gritty, as if something is stuck under the eyelid.
• Photophobia: Sensitivity to light, especially when the inflammation is moderate to severe.
• Reduced vision: Blurry vision can occur if the cornea becomes involved (keratitis).
• Swollen eyelids (blepharitis): Often accompanies the conjunctival inflammation.
• Granular or “filamentous” plaques: In some cases, tiny fungal hyphae form visible white or yellowish patches on the conjunctiva.

Causes and Risk Factors

Common fungal pathogens

• Aspergillus spp. – especially A. fumigatus, a ubiquitous mold found in soil and decaying vegetation.
• Fusarium spp. – another soil‑borne mold, notorious for ocular infections in warm climates.
• Candida albicans and other Candida species – yeasts that can overgrow when normal ocular flora is disrupted.
• Dematiaceous (pigmented) fungi – such as Curvularia and Exophiala, occasionally seen in tropical agricultural workers.

Pathogenesis

Fungal spores (conidia) become airborne or are introduced via contaminated hands, contact lenses, or ocular trauma. In a healthy eye, innate defenses (tear film, antimicrobial peptides) usually eradicate them. When these barriers are compromised—by trauma, chronic inflammation, or immunosuppression—the spores can germinate, forming hyphae that invade conjunctival tissue and provoke an inflammatory response.

Key risk factors

• **Environmental exposure** – farming, gardening, construction, or any activity that generates dust or plant debris.
• **Contact lens wear**, especially extended‑wear or poor hygiene.
• **Topical corticosteroids** or other immune‑modulating eye drops used for allergic or autoimmune eye disease.
• **Systemic immunosuppression** – HIV/AIDS, diabetes mellitus, chemotherapy, long‑term systemic steroids.
• **Ocular surface disease** – dry eye, blepharitis, meibomian gland dysfunction.
• **Previous ocular surgery** – especially corneal grafts or vitrectomy.

Diagnosis

Early and accurate diagnosis is crucial because antifungal therapy differs from the antibiotics used for bacterial conjunctivitis.

Clinical evaluation

• History taking – exposure to soil, contact lens use, recent steroid eye drops, systemic illnesses.
• Slit‑lamp examination – allows the clinician to visualize characteristic fungal plaques, hyphal filaments, or dense discharge.
• Fluorescein staining – helps identify corneal involvement (ulcers) that may accompany conjunctivitis.

Laboratory tests

1. Conjunctival scrapings or swab – collected with a sterile cotton-tipped applicator; sent for:
   • Direct microscopy (KOH wet mount) – rapid detection of hyphae or yeast cells.
   • Gram stain – may show fungal elements mixed with inflammatory cells.
   • Culture on Sabouraud dextrose agar – the gold standard; results usually available within 3–7 days.
2. Polymerase chain reaction (PCR) – molecular identification of fungal DNA; increasingly used for rapid diagnosis, especially when cultures are negative.
3. Sensitivity testing – determines which antifungal agents are most effective against the isolated organism.
4. Blood work (if systemic immunosuppression is suspected) – complete blood count, HIV test, glucose level.

Differential diagnosis

Conditions that can mimic fungal conjunctivitis include bacterial conjunctivitis, viral (adenoviral) conjunctivitis, allergic conjunctivitis, and early-stage ocular surface neoplasia. A careful eye exam and microbiological testing help separate them.

Treatment Options

Treatment combines pharmacologic therapy, procedural care, and supportive measures.

Antifungal medications

Drug	Formulation	Typical dosage	Comments
Natamycin	0.5 % ophthalmic suspension	One drop every hour while awake for 48 h, then q2‑4 h	First‑line for filamentous fungi (Aspergillus, Fusarium). FDA‑approved for keratitis; used off‑label for conjunctivitis.
Voriconazole	1 % ophthalmic solution	One drop q2 h for 48 h, then q4–6 h	Broad‑spectrum; good corneal penetration; monitor liver function if systemic therapy added.
Amphotericin B	0.15 % ophthalmic solution	One drop q4 h	Effective against Candida; can cause ocular irritation.
Fluconazole	Oral 200 mg daily	Used when Candida is identified or if topical therapy fails.

Therapy is usually continued for at least 7–14 days after the resolution of signs, to prevent relapse.

Adjunctive procedures

• Debridement – gentle mechanical removal of dense fungal plaques with a sterile cotton swab under slit‑lamp guidance.
• Therapeutic contact lenses – bandage lenses can protect the ocular surface and improve drug absorption, but only after infection is controlled.
• Intracameral or intrastromal injection – reserved for severe cases where the fungus has invaded deeper ocular layers.

Lifestyle and supportive care

• Cold compresses to soothe burning.
• Avoid rubbing the eyes – can spread fungi and worsen inflammation.
• Lubricating (preservative‑free) artificial tears 4–6 times daily to support tear film.
• Discontinue any non‑prescribed topical steroids until the infection clears (under physician guidance).

Living with Fungal Conjunctivitis

Daily management tips

1. Strict hand hygiene: Wash hands with soap for at least 20 seconds before touching your eyes or applying drops.
2. Adhere to medication schedule: Set alarms or use a medication app to avoid missed doses.
3. Keep contact lenses out: Remove lenses until the eye is completely healed; discard any lenses that were worn during the infection.
4. Protect your eyes from the environment: Wear sunglasses or protective goggles when outdoors in dusty or windy conditions.
5. Monitor symptoms: Keep a simple diary noting redness, discharge, pain, and visual changes. Report any worsening to your eye‑care professional.
6. Follow‑up appointments: Most clinicians will see you within 48‑72 hours of starting therapy, then weekly until resolution.

Impact on work and activities

Most patients can return to light office work within a few days if they avoid screen glare and keep eyes moist. Heavy physical labor, gardening, or any activity that exposes the eyes to dust should be postponed until the infection is fully resolved.

Prevention

• Hand and eye hygiene: Regular hand washing and avoiding touching the eyes with unclean hands.
• Contact lens safety: Use daily‑disposable lenses when possible; clean reusable lenses with approved solutions; replace lens cases every 3 months.
• Protective eyewear: Wear goggles while gardening, farming, or working with compost.
• Limit steroid exposure: Use topical corticosteroids only as prescribed and for the shortest duration necessary.
• Manage systemic risk factors: Keep diabetes under control, maintain a healthy immune system, and discuss any planned immunosuppressive therapy with your ophthalmologist.
• Environmental control: In high‑risk regions, use air filters or dehumidifiers indoors to reduce spore load.

Complications

If left untreated or inadequately treated, fungal conjunctivitis can lead to serious ocular sequelae:

• Corneal involvement (fungal keratitis): Can progress to corneal ulceration, scarring, and permanent vision loss.
• Orbital cellulitis: Rare but possible spread of infection behind the eye, causing pain, swelling, and systemic illness.
• Endophthalmitis: Intra‑ocular infection that threatens sight; requires urgent intra‑vitreal antifungal therapy.
• Chronic dry eye and scarring of the conjunctiva: May cause ongoing discomfort and may need surgical correction.
• Systemic dissemination: In severely immunocompromised patients, fungi can enter the bloodstream and affect other organs.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC (2022 Fungal Ocular Infections Surveillance Report), National Institutes of Health (NIH) – EyeHealth, World Health Organization (WHO) – Neglected Tropical Diseases, Cleveland Clinic – Eye Infections, Ophthalmology journals (JAMA Ophthalmology, American Journal of Ophthalmology).

```